CD7 and acute lymphoblastic leukemia: The initial human trial utilizing donor-derived CD7 CAR-T cells to treat R/R T-ALL, which was conducted by Pan J and his team in a single-center phase I clinical trial [54], involved infusing 20 patients with these cells.